This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Axle International Ltd.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Eric C. Soller
Introduction
Eric C. Soller is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of medical devices, particularly in the area of tissue regeneration. His innovative work focuses on developing solutions that enhance healing and reduce complications associated with surgical procedures.
Latest Patents
One of Eric C. Soller's key patents is titled "Scaffold comprising co-precipitated Collagen and glycosaminoglycan for inhibiting adhesion of body tissue layers." This device is designed to inhibit the adhesion of apposing human body tissue layers. The scaffold features a designated mean pore size, relative density, and degradation half-life. It can be strategically positioned between tissue layers at a wound site, allowing for remesothelialization without the formation of fibrous adhesions. The invention promotes contractile cell migration away from the wound site for a predetermined period, thereby enhancing internal tissue regeneration and facilitating the delivery of therapeutic agents in vivo.
Career Highlights
Eric C. Soller is associated with Axle International Ltd., where he continues to push the boundaries of innovation in medical technology. His work has garnered attention for its potential to improve patient outcomes and streamline surgical recovery processes.
Collaborations
Eric has collaborated with notable colleagues such as Brendan A. Harley and Eric Aiazian. These partnerships have contributed to the advancement of his research and the development of groundbreaking medical solutions.
Conclusion
Eric C. Soller exemplifies the spirit of innovation in the medical field through his patented inventions and collaborative efforts. His work not only addresses critical challenges in tissue adhesion but also paves the way for future advancements in medical technology.